Khan, A., Bhrdwaj, A., Sharma, K., Arugonda, R., Kaur, N., Chaudhary, R., Shaheen, U., Panwar, U., Natchimuthu, V., Kumar, A., Dey, T., Panicker, A., Prajapati, L., Shainy, N. K., Sahila, M. M., Bezerra Mendonca Junior, F. J., Hussain, T., Alrokayan, S., &
Anuraj Nayarisseri . (2026). Potential inhibitors of SARS-CoV-2 developed through machine learning, molecular docking, and MD simulation. Medicinal Chemistry, 22(5), 1–22 |
